BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 50 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,009 | -43.2% | 700 | 0.0% | 0.00% | – |
| Q2 2023 | $3,535 | +167.2% | 700 | 0.0% | 0.00% | – |
| Q1 2023 | $1,323 | +5.0% | 700 | 0.0% | 0.00% | – |
| Q4 2022 | $1,260 | +26.0% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -55.6% | 700 | -35.1% | 0.00% | – |
| Q3 2021 | $9,000 | 0.0% | 1,079 | +54.1% | 0.00% | – |
| Q2 2021 | $9,000 | -47.1% | 700 | 0.0% | 0.00% | – |
| Q1 2021 | $17,000 | -22.7% | 700 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | +4.8% | 700 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | +23.5% | 700 | +75.0% | 0.00% | – |
| Q2 2020 | $17,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $5,830,000 | 0.29% |
| K2 PRINCIPAL FUND, L.P. | 1,031,511 | $1,743,000 | 0.20% |
| Boxer Capital, LLC | 2,014,858 | $3,405,000 | 0.19% |
| DAFNA Capital Management LLC | 313,600 | $530,000 | 0.14% |
| Newtyn Management, LLC | 350,000 | $592,000 | 0.13% |
| Artal Group S.A. | 1,646,517 | $2,783,000 | 0.12% |
| Bellevue Group AG | 4,717,113 | $7,972,000 | 0.11% |
| MPM BioImpact LLC | 239,888 | $405,000 | 0.10% |
| RA Capital Management | 2,589,904 | $4,377,000 | 0.09% |
| Beacon Capital Management, LLC | 35,615 | $88,000 | 0.03% |